Skip to content
HOMETECH DIRECTORYNEWS & DEVELOPMENTSRELOCATEEMPLOYERSNEIGHBORHOODSABOUTSchedule a Call

Ann Arbor Medtech Companies (2026)

The 2026 hub for Ann Arbor medtech: HistoSonics (unicorn 2024), Terumo Cardiovascular, Akadeum, ONL, Strata Oncology, BedConnect, M3D, Akervall (SISU).

A2Hub Editorial· Rusty Roof Media· Updated May 4, 2026

Ann Arbor Medtech Companies (2026)

By A2Hub Editorial. Published 2026-04-22. Last updated 2026-04-22.

The verdict

Ann Arbor's medtech cluster is the deepest in Michigan and one of the most exit-tested in the Midwest. The category is anchored by HistoSonics, which crossed unicorn status in a 2024 majority-stake recapitalization led by K5 Global, Bezos Expeditions, and Wellington Management following the Edison system's October 2023 FDA De Novo clearance for non-invasive focused-ultrasound tumor ablation. By 2024 the company reported treatment of more than 2,000 patients across 50-plus U.S. medical centers. Around HistoSonics sits a working bench: Terumo Cardiovascular Systems (the largest single medical device employer in the region with more than 1,000 employees at 6200 Jackson Road), Akadeum Life Sciences (microbubble-based cell separation, $20 million-plus closed in June 2025), ONL Therapeutics (clinical-stage ocular neuroprotection), Strata Oncology (precision oncology network), BedConnect (post-acute care coordination), M3D Technologies (cancer imaging spinout), and Akervall Technologies (Saline-based, the SISU mouthguard maker that quietly built a global consumer-medical brand from Washtenaw County).

The exit lineage is what makes the cluster credible to outside investors. HandyLab sold to BD in 2009 for approximately $275 million; the molecular diagnostics platform from U-M chemical engineering founders Kalyan Handique and Sundu Brahmasandra had roughly 60 employees in Pittsfield Township at close. Accuri Cytometers sold to BD in March 2011 for $205 million; the Scio Township-based cytometry startup was a U-M Life Sciences Institute spinout. NeuMoDx (the follow-on diagnostics venture from the HandyLab team) was acquired by QIAGEN in September 2020. Three exits, hundreds of millions of dollars into local hands, and a pipeline of executives, engineers, and quality and regulatory operators who today populate HistoSonics, Akadeum, ONL, Strata Oncology, and the broader bench. That pattern is the most underrated reason Ann Arbor medtech keeps producing.

The infrastructure layer matters too. The Sartorius Center of Excellence at 3874 Research Park Drive ($100 million, 130,000 square feet, opened 2024-2025, won Ann Arbor SPARK's 2023 Business Development Project of the Year) anchors the bioanalytics service layer that medtech and diagnostics companies in particular depend on. Michigan Innovation Headquarters (MI-HQ) operates 290,000-plus square feet of wet-lab and flex space across Ann Arbor, Ypsilanti, and Detroit, hosting 90-plus companies and 800-plus members. The Coulter Translational Research Partnership funds 5-7 U-M projects per year (each pairing an engineering faculty member with a practicing clinician) at $100,000-plus each, which is the single most important program for moving a U-M medical device idea into a pre-commercial company. The MTRAC Life Sciences program adds translational funding on top.

The talent stack is U-M Biomedical Engineering, the U-M College of Engineering, Michigan Medicine clinical faculty, and the LSI/Pharmacy/Public Health adjacencies. Arboretum Ventures (more than $1 billion raised across six funds, Fund VI at $268 million in 2023, 150-plus investments) is the regional capital anchor, with focused medical device, diagnostics, and life science tools investing as its house specialty. Below are the companies that matter.

The Companies

  • HistoSonics is Ann Arbor's most consequential medtech story of the last decade and Michigan's newest unicorn. Founded in 2009 out of U-M research on histotripsy, a non-invasive focused-ultrasound technique that mechanically destroys tissue without heat or incision. The Edison system received FDA De Novo clearance in October 2023. By 2024 the company reported treatment of more than 2,000 patients across 50-plus U.S. medical centers. A 2024 majority-stake recapitalization led by K5 Global, Bezos Expeditions, and Wellington Management valued HistoSonics at more than $1 billion. Corporate headquarters now sit in Plymouth, Michigan, but the research pedigree, clinical collaborators, and engineering pipeline remain anchored in Ann Arbor and U-M.

  • Terumo Cardiovascular Systems is Ann Arbor's largest medical device employer, full stop. Terumo's cardiovascular division runs its global headquarters out of 6200 Jackson Road, Ann Arbor, MI 48103, with more than 1,000 employees on site as of recent public reporting. The business makes heart-lung machines, perfusion products, and cardiovascular imaging systems. For engineers who want medical device work without moving to Boston or Minneapolis, Terumo is the obvious local choice and the quiet center of the regional medtech labor market.

  • Akadeum Life Sciences commercialized buoyancy-activated cell sorting (BACS), a microbubble-based technology for separating cells without magnets or centrifuges. Founded in 2014 in Ann Arbor. The Alerion cell separation system launched in 2023. Closed a financing round of more than $20 million in June 2025. Textbook Ann Arbor medtech: U-M-adjacent research, local capital led by Arboretum, product shipping to research and clinical labs worldwide.

  • ONL Therapeutics is clinical-stage ocular neuroprotection. U-M spinout, HQ Ann Arbor. Developing small-molecule therapies intended to halt photoreceptor cell death in retinal diseases. Cross-listed on the biotech hub because the line between medtech and therapeutics blurs in ophthalmology; included here because the device-and-delivery side of ophthalmic medicine is part of the same Ann Arbor talent pool.

  • Strata Oncology runs the Strata Trial precision oncology network. Founded in 2015 by Dan Rhodes and Scott Tomlins (both U-M) with Keith Flaherty of Mass General. HQ Ann Arbor. Raised what press releases described as a $90 million round in July 2021. Ships StrataNGS tumor sequencing and Strata Select for matched-trial enrollment across community health systems and pharma partners. Sits at the intersection of diagnostics, data, and clinical-trial enrollment infrastructure.

  • BedConnect is the hospital post-acute care coordination platform. Ann Arbor early-stage. Won the 2025 Invest360 round at $50,000, plus $325,000 from PitchMI including $75,000 from Corewell Health Ventures. Solving the bed-availability and discharge-coordination problem that consumes operations time at every regional hospital.

  • M3D Technologies is a U-M cancer medical imaging spinout. SPARK Capital portfolio. Ann Arbor early stage. Specific funding totals not yet cleanly public; included because the U-M imaging research pipeline regularly produces companies of this type and M3D is a current example.

  • Akervall Technologies is the Saline-based maker of SISU mouthguards. Founded by Sassa and Jan Akervall (Jan is a clinical professor of otolaryngology at U-M Medicine). The company built a global consumer-medical brand around a thin, custom-fit mouthguard sold direct-to-consumer and through dental offices. Headquartered in Saline, just south of Ann Arbor. Akervall is the reminder that Ann Arbor medtech is not all six-figure-device-with-FDA-PMA hardware; some of it is durable consumer brands that ship hundreds of thousands of units a year.

The exit lineage and why it matters

Three previous exits set the foundation for everything above. HandyLab to BD in 2009 for approximately $275 million put the molecular diagnostics platform team into BD and freed up local capital for the next venture. Accuri Cytometers to BD in March 2011 for $205 million did the same on the cytometry side. NeuMoDx to QIAGEN in September 2020 was the follow-on from the HandyLab team and validated that the same operators could do it twice. Each of those exits seeded angel investors, board members, advisors, and senior hires for the next generation of companies. HistoSonics's commercial team, Akadeum's regulatory team, and Strata Oncology's data engineering organization all benefit from the bench depth those three exits created.

The Coulter Translational Research Partnership at U-M deserves a mention too. By design, every Coulter-funded project pairs a U-M engineering faculty member with a practicing clinician at Michigan Medicine, which is the structural reason so many U-M medical device ideas actually become companies rather than expiring as papers. The Coulter program is small in dollars but outsized in pipeline impact.

Adjacent verticals

Medtech in Ann Arbor overlaps three other categories on this site. Ann Arbor biotech companies is the closest sibling: Esperion, ONL Therapeutics, Strata Oncology, Genomenon, Workit Health, and the broader therapeutics-and-digital-health half of the cluster live there in greater detail. Ann Arbor AI companies overlaps via Genomenon (genomic interpretation), CircNova (RNA design), and Innsightful (mental health monitoring devices). Ann Arbor SaaS companies overlaps via ArborMetrix, Ripple Science, and the clinical-research software stack used across the medical device industry.

Related

FAQ

How many medtech companies are in Ann Arbor? The publishable, named cluster of active commercial medtech and medical device companies in the Ann Arbor region as of April 2026 is eight: HistoSonics (corporate HQ Plymouth, Michigan, but R&D and clinical collaborators rooted in U-M and Ann Arbor), Terumo Cardiovascular, Akadeum, ONL Therapeutics, Strata Oncology, BedConnect, M3D Technologies, and Akervall Technologies. Add the historical exits (HandyLab, Accuri, NeuMoDx) operating now under their acquirers (BD, QIAGEN) and the regional medtech footprint expands meaningfully. SPARK's broader life-sciences count includes hundreds of small specialty firms and contract research organizations.

Who is the largest medtech employer in Ann Arbor? Terumo Cardiovascular Systems, with more than 1,000 employees at 6200 Jackson Road, is the largest single medtech and medical device employer in Ann Arbor. HistoSonics is the largest startup-trajectory medtech employer; corporate headquarters are now in Plymouth, Michigan, but the company maintains deep Ann Arbor ties.

What is the salary range for medtech roles in Ann Arbor? Per Glassdoor and Salary.com aggregates for 2024-2025, mid-level mechanical and biomedical engineers in Ann Arbor medtech cluster around $90,000 to $135,000 base, with senior engineers in the $135,000 to $185,000 base range. Regulatory affairs, clinical operations, and quality engineering roles fall in similar bands. Software engineering inside medical device companies (HistoSonics, Strata Oncology) pays closer to the AA software bands ($140,000 to $200,000 mid to senior). HistoSonics commercial roles include unicorn-stage equity packages on top.

Where is the Ann Arbor medtech cluster geographically? Three nodes. The Jackson Road and west-side industrial corridor for Terumo Cardiovascular and several legacy device operations. Research Park Drive and the Ellsworth corridor for Sartorius bioanalytics, Akadeum, and the broader research-park tenancies. Saline (just south of Ann Arbor) for Akervall Technologies and Quantum Signal AI's Ford-owned medical-imaging-adjacent team. Plus the Pittsfield Township and Scio Township edges for the historical HandyLab and Accuri footprints absorbed into BD operations.

What is the difference between medtech and biotech in Ann Arbor? Medtech means devices and diagnostics, regulated through FDA 510(k) or De Novo pathways, with engineering-heavy hiring and earlier revenue (HistoSonics, Terumo, Akadeum, BedConnect). Biotech in the strict sense means therapeutics: drugs, gene therapies, cell therapies, RNA platforms, regulated through FDA NDA or BLA pathways, with multi-year clinical trials and PhD-heavy hiring (Esperion, ONL, Strata Oncology, TSRL). The same pool of investors and U-M feeder backs both, but the operating realities are different. We split them across two hubs on purpose.

Are HistoSonics, NeuMoDx, and HandyLab still in Ann Arbor? HistoSonics's corporate headquarters are in Plymouth, Michigan, but the company's research pedigree, clinical collaborators (Michigan Medicine), and engineering pipeline remain anchored in Ann Arbor and U-M. The company is properly listed as a Michigan medtech rooted in the Ann Arbor cluster. NeuMoDx operates today as a QIAGEN business unit; the local team and operations were retained post-acquisition in 2020. HandyLab's MAX platform is still on the market under BD; the founding team has long since rolled into other ventures (NeuMoDx and beyond), but the engineering legacy in the regional talent pool remains.